ON THE RECORD
Sermorelin: frequently asked questions, answered from the literature
Direct, cited answers to the questions researchers and readers actually ask — including the honest gaps.
Does sermorelin actually help with sleep, or is it waking me up instead?
GHRH promoted slow-wave sleep in healthy men in controlled studies [10], and the sleep-endocrine effect depends on the time of administration [11]. These are research findings in study settings, not a personal-use guarantee; individual experiences in research-user communities vary, and the literature describes a circadian-gated effect rather than a uniform one.
Why is it recommended to inject sermorelin at night?
Endogenous growth hormone is secreted in pulses, most prominently during slow-wave sleep, and GHRH's sleep-endocrine effects are time-of-administration dependent [11]. Bedtime dosing was the protocol used in pediatric and aging trials — for example, 30 mcg/kg/day at bedtime [2]. This is described as a studied protocol, not a personal dosing recommendation.
When is the best time to take sermorelin?
Bedtime administration was used in the pediatric efficacy trial and in aging studies, aligning with the nocturnal GH pulse, and GHRH's sleep-endocrine effect is circadian-dependent [11][2]. This describes study timing, not a use instruction; the record reports what was given when, not a schedule a reader should adopt.
What is sermorelin?
Sermorelin (sermorelin acetate) is a synthetic 29-amino-acid peptide matching the 1-29 N-terminal fragment of growth hormone-releasing hormone (GHRH) — the shortest fragment that retains full GHRH-receptor activity [1]. It is a pituitary GH secretagogue, formerly an FDA-approved pediatric growth-hormone-deficiency drug and now prepared by compounding pharmacies.
What does sermorelin do to the body?
It binds GHRH receptors on anterior-pituitary somatotrophs, activating the cAMP/PKA pathway to stimulate the body's own pulsatile growth-hormone release, which in turn raises hepatic IGF-1 [1]. Because it acts upstream of the pituitary, somatostatin and IGF-1 feedback stay intact, preserving the natural pulsatile pattern of GH secretion.
Does sermorelin work?
In its approved pediatric indication, once-daily subcutaneous GHRH(1-29) accelerated growth in deficient children (height velocity ~4.1 to ~7-8 cm/year) [2]. In older men, 14 days of dosing reversed age-related declines in GH and IGF-1 [3]. Adult anti-aging efficacy is less established — an editorial called secretagogue anti-aging use "not yet ready for prime time" [14].
How long does it take for sermorelin to work?
Acute growth-hormone release follows a single dose within hours — GH stayed elevated about 3 hours after an intravenous dose [13] — while the aging study measured GH/IGF-1 changes over 14 days [3] and the pediatric growth endpoint was assessed over the first year [2]. These timelines are study endpoints, not personal expectations.
How does sermorelin compare to CJC-1295?
Both act on the GHRH receptor, but native sermorelin has a very short plasma half-life (~10-12 minutes), which motivated longer-acting analogs [13]. CJC-1295 with DAC uses a drug-affinity-complex (albumin-binding) strategy, and PEGylation is another half-life-extension approach for GRF analogs [5]. The mechanism is shared; the duration of action is the difference.
Sermorelin vs ipamorelin: what is the difference?
Sermorelin is a GHRH analog acting on the GHRH receptor; ipamorelin is a growth-hormone-releasing peptide (GHRP) acting on the ghrelin/GHS receptor — a different mechanism [4]. In rats, the GHRPs ipamorelin and GHRP-6 increased bone mineral content [4], an effect attributed to that distinct class rather than to GHRH analogs.
What is sermorelin used for?
Historically it was an FDA-approved prescription product (NDA 020443) to evaluate and treat growth-hormone deficiency and short stature in children, and it was used diagnostically as a GHRH stimulation agent. Adult GH-axis research has examined aging, body composition, sleep, and cognition; those non-pediatric uses are research contexts, not approved indications.
Does sermorelin burn fat?
Direct sermorelin fat-loss trials are limited. The body-composition evidence largely comes from the stabilized GHRH analog tesamorelin and from a cognition trial in which IGF-1 rose and percent body fat fell 7.4% [7]. Pulsatile GH also contributes to fasting lipolysis. These are research findings, not a weight-loss claim.
Is sermorelin effective for weight loss?
No sermorelin study establishes it as a weight-loss treatment. The closest controlled body-composition data come from tesamorelin (a related GHRH analog) and from the GHRH cognition trial that reported a 7.4% reduction in percent body fat [7]. Anti-aging and body-composition marketing outpaces the direct sermorelin evidence.
Does sermorelin affect testosterone?
Sermorelin acts on the GH/IGF-1 axis, not directly on the gonadal axis; the literature here reports GH and IGF-1 outcomes [3] and does not establish a direct testosterone effect. Research-community interest in this link is not supported by a specific sermorelin testosterone finding in the corpus.
Will sermorelin raise my IGF-1 levels?
In healthy older men, GHRH(1-29) twice daily for 14 days produced dose-related increases in GH and IGF-1, with high-dose values no longer differing from young men [3]. A related GHRH analog raised IGF-1 by 117% within the physiologic range in a cognition trial [7]. Reported as study outcomes, not a personal prediction.
Does sermorelin build muscle?
The corpus contains no controlled sermorelin muscle-hypertrophy trial. GH/IGF-1-axis modulation has been discussed in reviews as a candidate strategy against age-related muscle loss (sarcopenia), but that is framing, not proof [15]. Lean-mass claims outpace the direct evidence.
How does sermorelin differ from direct HGH injections?
Sermorelin stimulates the pituitary to release the body's own GH in its natural pulsatile pattern, leaving somatostatin and IGF-1 feedback intact, whereas recombinant GH supplies exogenous hormone directly [1]. An editorial argued the secretagogue route may be more physiologic for adult GH insufficiency [6].
Does sermorelin affect the brain?
GHRH administration has measurable neuroendocrine effects: in a controlled trial a GHRH analog had a favorable effect on cognition in older adults [7], and GHRH influences slow-wave sleep, the sleep stage tied to nocturnal GH. These are research observations in study populations, not a cognitive-enhancement claim.
Can sermorelin or GHRH improve cognition in older adults?
In a randomized, double-blind, placebo-controlled trial of 152 older adults (including 66 with mild cognitive impairment), 20 weeks of a daily GHRH analog had a favorable effect on cognition (P=0.03; executive function P=0.005), alongside a 117% IGF-1 rise and a 7.4% body-fat reduction [7]. Promising, but a single trial of a related analog — not a treatment claim for sermorelin.
What are the side effects of sermorelin?
Reported adverse effects in studies were generally mild, with injection-site reactions the most common; adverse events were described as mild in the GHRH-analog cognition trial [7]. Because GH and IGF-1 are mitogenic, chronically raising them carries a theoretical oncologic consideration, and long-term adult safety data are limited. This is not medical advice.
Is 3 months of sermorelin enough?
Study durations vary by endpoint: acute GH release appears within hours, GH/IGF-1 shifts were measured over 14 days [3], and the pediatric growth endpoint spanned the first year of therapy [2]. The corpus does not define an adult "course length"; the durations described are study timeframes, not protocols to follow.
Sermorelin before and after: what changes do studies report?
Measured before/after changes include accelerated height velocity in deficient children (~4.1 to ~7-8 cm/year) [2], reversal of age-related GH/IGF-1 declines in older men [3], and — for a related GHRH analog — a 117% IGF-1 increase with a 7.4% body-fat reduction [7]. These are trial outcomes, not personal results.
How does sermorelin work to stimulate growth hormone production?
It binds the GHRH receptor (a class B GPCR) on pituitary somatotrophs, activating Gs/adenylate-cyclase/cAMP/PKA signaling to increase GH gene transcription and pulsatile GH release; downstream, GH drives hepatic IGF-1, while somatostatin and IGF-1 feedback — preserved by this upstream action — keep the pattern pulsatile [1].